GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (LSE:CNSL) » Definitions » Cyclically Adjusted Price-to-FCF

Cambridge Nutritional Sciences (LSE:CNSL) Cyclically Adjusted Price-to-FCF : (As of Dec. 14, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cambridge Nutritional Sciences Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cambridge Nutritional Sciences Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Cambridge Nutritional Sciences's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambridge Nutritional Sciences Cyclically Adjusted Price-to-FCF Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cambridge Nutritional Sciences Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cambridge Nutritional Sciences's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's Cyclically Adjusted Price-to-FCF falls into.



Cambridge Nutritional Sciences Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Cambridge Nutritional Sciences's Cyclically Adjusted FCF per Share for the fiscal year that ended in Mar24 is calculated as:

For example, Cambridge Nutritional Sciences's adjusted Free Cash Flow per Share data for the fiscal year that ended in Mar24 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar24 (Change)*Current CPI (Mar24)
=0.002/131.6000*131.6000
=0.002

Current CPI (Mar24) = 131.6000.

Cambridge Nutritional Sciences Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -0.008 99.600 -0.011
201603 -0.005 100.400 -0.007
201703 -0.006 102.700 -0.008
201803 -0.033 105.100 -0.041
201903 -0.018 107.000 -0.022
202003 -0.011 108.600 -0.013
202103 -0.030 109.700 -0.036
202203 -0.025 116.500 -0.028
202303 -0.014 126.800 -0.015
202403 0.002 131.600 0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cambridge Nutritional Sciences  (LSE:CNSL) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Cambridge Nutritional Sciences Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cambridge Nutritional Sciences Business Description

Traded in Other Exchanges
Address
One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis to the general public, clinics, and health professionals as well as supplying the point-of-care Food Detective test. The Corporate segment consists of centralised corporate costs which are not allocated to the trading activities of the group. The company generates the majority of its revenue from the Health and Nutrition segment.